HRT Financial’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-377
Closed -$26K 4290
2021
Q3
$26K Buy
+377
New +$42.9K ﹤0.01% 3125

Other funds holding ASLN

HRT Financial's ASLN Position: Q4 2021 in Review

HRT Financial sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2021, closing a stake of 377 shares — an estimated $26K sold.

HRT Financial first reported a position in ASLN in Q3 2021 and held it in 1 quarter. The position peaked at $26K in Q3 2021. 33 funds tracked by Wall St. Rank hold ASLN as of Q4 2021.

  • HRT Financial reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 377 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2021, an estimated $26K.
  • HRT Financial first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • HRT Financial's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $26K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.